- Home
- LCTX vs AFCG Comparison
LCTX vs AFCG Comparison
Compare LCTX & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCTX
- AFCG
- Stock Information
- Founded
- LCTX 1990
- AFCG 2020
- Country
- LCTX United States
- AFCG United States
- Employees
- LCTX N/A
- AFCG N/A
- Industry
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- AFCG Real Estate Investment Trusts
- Sector
- LCTX Health Care
- AFCG Real Estate
- Exchange
- LCTX Nasdaq
- AFCG Nasdaq
- Market Cap
- LCTX 95.2M
- AFCG 113.0M
- IPO Year
- LCTX N/A
- AFCG 2021
- Fundamental
- Price
- LCTX $0.49
- AFCG $5.11
- Analyst Decision
- LCTX Strong Buy
- AFCG Buy
- Analyst Count
- LCTX 5
- AFCG 7
- Target Price
- LCTX $4.20
- AFCG $11.00
- AVG Volume (30 Days)
- LCTX 860.2K
- AFCG 129.0K
- Earning Date
- LCTX 05-13-2025
- AFCG 05-14-2025
- Dividend Yield
- LCTX N/A
- AFCG 25.07%
- EPS Growth
- LCTX N/A
- AFCG 84.02
- EPS
- LCTX N/A
- AFCG 0.96
- Revenue
- LCTX $9,557,000.00
- AFCG $41,036,509.00
- Revenue This Year
- LCTX N/A
- AFCG N/A
- Revenue Next Year
- LCTX $232.66
- AFCG $23.25
- P/E Ratio
- LCTX N/A
- AFCG $5.51
- Revenue Growth
- LCTX 19.42
- AFCG N/A
- 52 Week Low
- LCTX $0.37
- AFCG $4.34
- 52 Week High
- LCTX $1.40
- AFCG $10.88
- Technical
- Relative Strength Index (RSI)
- LCTX 54.19
- AFCG 40.41
- Support Level
- LCTX $0.45
- AFCG $5.27
- Resistance Level
- LCTX $0.49
- AFCG $5.87
- Average True Range (ATR)
- LCTX 0.03
- AFCG 0.25
- MACD
- LCTX 0.00
- AFCG -0.00
- Stochastic Oscillator
- LCTX 72.25
- AFCG 20.83
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.